Minoru Tagaya, President of Nippon Venture Capital, invests primarily in early-stage Japanese companies across. See sector focus and contact routes.
Minoru Tagaya, President of Nippon Venture Capital, invests primarily in early-stage Japanese companies across communications, software, life sciences, and environmental technologies. His notable portfolio includes LUCA Science (which raised a $30.3M Series B), WHILL, Cyfuse Biomedical, and TOKIWA-Bio, reflecting a focus on high-growth technology and healthcare sectors. The firm’s distinctive thesis leverages its origin as the corporate venture capital arm of Nippon Telegraph and Telephone to provide portfolio companies with extensive corporate and academic networks to accelerate growth toward IPOs.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Tokyo when building a target list.
Investors like Minoru Tagaya · Full investor directory · Investor access · Company funding database